Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2012 / Article

Research Article | Open Access

Volume 2012 |Article ID 176385 | https://doi.org/10.1155/2012/176385

S. Saha, M. K. Mukhopadhyay, P. D. Ghosh, D. Nath, "Effect of Methanolic Leaf Extract of Ocimum basilicum L. on Benzene-Induced Hematotoxicity in Mice", Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 176385, 7 pages, 2012. https://doi.org/10.1155/2012/176385

Effect of Methanolic Leaf Extract of Ocimum basilicum L. on Benzene-Induced Hematotoxicity in Mice

Academic Editor: Senthamil R. Selvan
Received18 May 2012
Revised13 Jul 2012
Accepted26 Jul 2012
Published05 Sep 2012


The aim of the present study was to investigate the protective role of methanolic leaf extract of Ocimum basilicum L. against benzene-induced hematotoxicity in Swiss albino mice. GC analysis and subacute toxicity level of the extract were tested. Mice were randomly divided into three groups among which II and III were exposed to benzene vapour at a dose 300 ppm × 6 hr/day × 5 days/week for 2 weeks and group I was control. Group III of this experiment was treated with the leaf methanolic extract at a dose of 100 mg/kg body weight, a dose in nontoxic range. Hematological parameters (Hb%, RBC and WBC counts), cell cycle regulatory proteins expression and DNA fragmentation analysis of bone marrow cells was performed. There was an upregulation of p53 and p21 and downregulation of levels of CDK2, CDK4, CDK6, and cyclins D1 and E in leaf extract-treated group. DNA was less fragmented in group III compared to group II ( 𝑃 < 0 . 0 5 ). The present study indicates that the secondary metabolites of O. basilicum L. methanolic leaf extract, comprising essential oil monoterpene geraniol and its oxidized form citral as major constituents, have modulatory effect in cell cycle deregulation and hematological abnormalities induced by benzene in mice.

1. Introduction

Natural products have been investigated for promising new leads in pharmaceutical development [1, 2] as well as promising new source of therapeutic agents in plant secondary metabolites that characterize certain plants or plant group [3]. Interest in these secondary metabolites has been focused upon their medicinal properties [4]. Monoterpenes have long been recognized to possess significant medicinal values especially to cancer cells. Monoterpenes are nonnutritive dietary components found in the essential oils of citrus fruits, cherry, mint, and herbs. They function physiologically as chemoattractants or chemorepellents [5], and they are largely responsible for the distinctive fragrance of many plants. These 10 carbon isoprenoids are derived from the mevalonate pathway in plants.

A number of dietary monoterpenes have antitumor activity, exhibiting not only the ability to prevent the formation or progression of cancer, but also to regress existing malignant tumors. A variety of dietary monoterpenes have been shown to be effective in the chemoprevention and chemotherapy of cancer [610]. The cancer suppressing chemopreventive activity of monoterpenes during the promotion phase of mammary and liver carcinogenesis may be due to inhibition of tumor cell proliferation, acceleration of the rate of tumor cell death, and/or induction of tumor cell differentiation [11]. Now, monoterpene research is progressing into human clinical trials for chemotherapeutic activity from the last decade. Monoterpenes also possess many characteristics of ideal chemopreventive agents, namely, efficacious antitumor activity, commercial availability, low cost, oral bioavailability, and low toxicity, making it feasible to begin considering them for human cancer chemoprevention testing.

Ocimum basilicum L. popularly known as Tulsi in Hindi and “Sweet Basil” in English in one of the sacred herbs for Hindus in the Indian subcontinent. And India has one of the oldest, richest, and most diverse cultural living traditions associated with the use of medicinal plants [12]. The entire plant of Ocimum basilicum L. has medicinal value although mostly the leaves, and sometimes the seeds, are used. It has a versatile role in traditional medicine. Earlier studies in particular, the leaves of Ocimum basilicum L. offer promise to biologically active constituents such as insect repellent, nematocidal, antibacterial, antifungal and antioxidants properties [1316]. It is also used as an antiemetic agent [17]. In addition, more recently [18], anticancer activity of Ocimum basilicum L. extract and its fractions was evaluated using human cancer cell lines.

Benzene is an ubiquitous environmental chemical that cause different types of haematotoxicity. It is known to be a very volatile liquid, with several organic and inorganic constituents. These vapors constitute various components of pollutants in the air, which are of great environmental and human health concern. Exposures to these pollutants are common in the refineries, oil fields, refueling stations, petrochemical industries, and motor mechanical workshops. A good percent of human populace is directly or indirectly exposed to these pollutants in the course of their day-to-day activities. Generally, those occupationally exposed constitute the population at greater risk of frequent exposure [19, 20]. The potential health hazards associated with chronic or subchronic exposure to these ubiquitous pollutants in the environment has attracted the attention of the general public and scientific community in particular.

Exposure of mice to benzene vapour induces inflammatory responses, oxidative stress, alterations in cell cycle progression and DNA damage, and so forth, which together have been implicated in various blood diseases, including the development of acute myeloid leukemia [21, 22]. In this regard, the benzene-exposed animal model can act as a significant template for the study of environmental-occupational cancers with respect to different parameters measuring clinical prevention intervention. The present study was designed to determine whether oral application of the methanolic leaf extracts Ocimum basilicum L. had any role in prevention of benzene-induced alterations in cell cycle progression in mouse bone marrow.

2. Materials and Methods

2.1. Plant Material Collection

Fresh leaves of Ocimum basilicum L. were collected from medicinal and aromatic plant garden, Department of Botany, University of Kalyani, Kalyani, India, in August of 2011, which is located at 22°57′N latitude, 88°22′E longitude with an average altitude of 9.75 m above mean sea level. The taxonomic identification of plant material was confirmed by Dr. G. G. Maity, Professor of Taxonomy, Taxonomy and Plant systematic Unit, Department of Botany, University of Kalyani. The voucher specimens (PDG/Bot. 136) was deposited and preserved in the Department of Botany, University of Kalyani, Kalyani, India, for reference.

2.2. Other Materials

The primary antibodies specific for cyclin D1, cyclin E, CDK2, CDK4, CDK6, Cip1/p21, p53 and 𝛽 -actin and the secondary antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). All other chemicals used in our experiments were of analytical grade. Blood collected from subacute treatment group was used for the estimation of serum biochemical parameters like serum glutamate oxaloacetate transaminase (SGOT), serum glutamate pyruvate transaminase (SGPT), serum alkaline phosphatase (ALP), serum total cholesterol, total protein, urea, uric acid, and creatinine contents by using reagent kits (Span Diagnostics, Surat, India), following the instructions of manufacturer.

2.3. Experimental Animals

Six- to eight-week-old Swiss albino male mice (Mus musculus) were purchased from a reputed supplier at a regular basis from maintained strain and were housed in a stainless steel wire cages (Tarsons, India) and maintained on a 12-hour light-dark cycle. Pellet diet (West Bengal Diary and Poultry Development Corp. Ltd., Kalyani Industrial Area, Kalyani) was provided ad libitum except during the 6-hour daily period of benzene inhalation. Water was supplied ad libitum automatically through the tubing throughout the study.

Benzene (MERCK, India) vapour was generated by heating liquid benzene to 16°C and channeled into the inhalation chamber. The groups of experimental mice were exposed 300 ppm, benzene for 6 hr/day, 5 days/week for 2 weeks in 1.3 m3 inhalation chambers (S.B. Equipments, WB, India) and one control group was exposed to ambient air for the same time duration, interval, and periods. Benzene concentration in the chambers was monitored at half-hour. intervals during daily exposures. The temperature and humidity in the chambers were automatically maintained at 2 4 ± 1 °C and 5 5 ± 1 0 % , respectively. This animal can act as a model for benzene-exposed haematotoxicity and leukemogenesis leading to secondary acute myelocytic leukemia (unpublished data).

2.4. Preparation of Plant Extract

Secondary metabolites, including flavonoids and other phenolic compounds, were extracted from dry leaves of Ocimum basilicum L. Collected plant material was dried in shade and ground in a grinder with a 2 mm diameter mesh. The dried and powdered plant materials (100 gm) were extracted successively using with 500 ml of methanol (1 : 5 w/v) by using Soxhlet extractor for 24 hours at a temperature not exceeding the boiling point of the solvent [23]. The extracts were filtered using Whatman filter paper (Number 1) and then concentrated in vacuo at 40°C using a Rotary evaporator. The residues obtained were stored in dark glass bottles at −20°C in air tight containers for further tests. The yield of the oils was calculated based on dried weight of plant materials.

2.5. GC-MS and GC-FID Analysis

GC-MS analyses of the essential oils were performed on a Hewlett-Packard gas chromatograph, model 6890, equipped with a FID, using HP-5MS capillary column (30 m length × 0.25 mm i.d × 0.25  𝜇 m film thickness), Agilent Technologies, USA. The injector was set at 250°C and the detector at 280°C, respectively. Oven temperature of the chromatogram was raised from 60°C to 280°C, respectively, at the heating rate of 10°C/min then isothermally held for 5 min. The injector volume was 1.0  𝜇 L. The solvent delay was 2 min and injected in a split ratio of 1 : 10. Helium was used as carrier at 15 P.S.I. inlet pressure. The essential oil constituents were identified by comparison of their GC retention indices (RI) and mass spectra with those of the authentic standard compounds. Quantification of the relative amount of the individual components was performed according to the area percentage method.

2.6. Subacute Toxicity Study of the Plant Extract

The crude methanolic leaf extracts were evaluated for their toxicity in O. basilicum L. noninfected male Swiss albino mice aged six to eight weeks and weighing 22–28 g. For the test of toxicity of the extract, 30 mice were randomly divided into three groups of ten animals (5 males and 5 females) per cage. Before oral administration of a dose, the mice were fasted for one to two hrs [24]. Then the extract was dissolved in distilled water and administered daily by oral gavage to the mice, groups II and III and the control group (group I) receiving respective volume of distilled water (vehicle), for 29 days. The mice in group II were given orally the extract of O. basilicum L. at a dose of 50 mg/kg, and the mice in group III were given the extract at dose of 1500 mg/kg of body weight. Then, the mice were observed continuously for one hr after the treatment; intermittently for four hrs, and thereafter over a period of 29 days. The mice were observed for gross behavioral changes, coat conditions, discharge, movement, body weight changes, serum biochemical parameters, hematological parameters, and mortality for 30 days to test subacute toxicity.

2.7. Hematological Parameters

After completion of the treatment with plant extract, the animals were made to fast overnight and sacrificed on the 30th day by decapitation and blood was collected. Blood hemoglobin concentration (g%) was determined using Sahli’s hemoglobinometer and total WBC and RBC were counted using Neubauer’s hemocytometer [25]. Other blood parameters including platelet count, differential count of monocyte, lymphocyte, neutrophil and differentials of RBC such as hematocrit, MCV, MCH, and MCHC were performed.

2.8. Bone Marrow Sampling

The femur bone of the sacrificed experimental mice was dissected and both the proximal and distal ends were removed. Phosphate buffer solution of pH 7.2 was injected gently into one end of the shaft. This process was followed to flush out the bone marrow through the opposite end into a collection vessel to prepare single cell suspension within one hour of stopping benzene inhalation.

2.9. Immunoblotting

Protein extracts of the bone marrow were prepared using 5 different animals individually by sonicating femoral bone marrow cells in a cell lysis buffer containing 20% SDS, 2 mM phenylmethyl sulphonyl fluoride, and a protease inhibitor/phosphate inhibitor [26]. Protein concentration was quantified using Bradford method [27]. Protein extracts from bone marrow (15  𝜇 g for p21 and 10  𝜇 g for other) were denatured, subjected to 12% (W/V) SDS-PAGE, and then transferred to PVDF membranes. After blocking nonspecific binding sites by incubating the membranes with 5% nonfat dried milk and 0.1% Tween 20 in Tris buffered saline (TTBS, pH 7.4) for 1 hour at room temperature, the membranes were incubated overnight at 4°C in the presence of diluted primary antibodies. The membranes were then washed with TTBS and incubated with 1 : 2000 horseradish-peroxidase conjugated secondary antibodies for 50 minutes at room temperature. To visualize the bands, the membranes were treated with a detection reagent for 1 minute. Band densities were measured using an image analyzer (image J, NIH).

2.10. DNA Fragmentation Assay

DNA was extracted from bone marrow single cell preparation (as mentioned before) using reagents and protocol suggested by Bangalore Genei (PI.NO: KT23). DNA concentration was measured at 260 nm using a spectrophotometer (Varian, Germany). DNA extracts were then subjected to 0.8% agarose gel electrophoresis using 1X TAE buffer as running buffer (composition: 40 mM Tris-acetate, 1mM EDTA) and ethidium bromide (final concentration into gel 0.5  𝜇 g/mL) as staining agent. 5  𝜇 L of 100 bp DNA ladder was loaded into one well in each assay. Finally, the gel was visualized and photographed using a gel documentation system (Genei image system).

2.11. Treatment of Benzene-Exposed Mice with Crude Methanolic Leaf Extract

Since no sign of toxicity of the plant extract was found in both low- and high-dose of plant extract-treated group, benzene-exposed mice were treated with the extract at a dose of 100 mg/kg body weight orally from the date of commencement of benzene exposure for 4 weeks daily. Control group of mice were treated with respective volume of distilled water containing 10% DMSO following the same schedule. During treatment, mice were supplied pelleted feed and water ad libitum (Table 1).


INot received any treatment
IIBenzene exposed, received only vehicle, distilled water containing 10% DMSO
IIIBenzene exposed, received plant extract suspended in distilled water containing 10% DMSO at a dose of 100 mg/kg body weight for 4 weeks

2.12. Ethical Clearance

The protocol used in this study was approved by the animal ethical committee, Department of Zoology, University of Kalyani (under Committee for the Purpose of Control and Supervision of Experiments on Animals, India).

2.13. Statistical Analysis

The two-tailed Students t-test was done to determine significance of differences between benzene-exposed and plant leaf extract-treated group to control group. Differences considered as significance at 𝑃 < 0 . 0 5 level.

3. Results and Discussion

3.1. Essential Oil Profiles of O. basilicum L. Leaves

The simple quantitative analysis of the crude methanolic extract showed remarkable variations in essential oil composition of O. basilicum L. from West Bengal. The yield of the essential oils obtained from dry leaf of O. basilicum L. was 1.77% (w/v) and the dominant or major constituents in sample were geraniol and citral ranging between 34.89% and 23.51% of the total oils (Table 2, Figure 1). Although methyl chavicol, linalool, methyl cinnamate, methyleugenol, eugenol, and geraniol are reported as major components of the oils of different chemotypes of O. basilicum L. [2830]. The variation in the oil composition could be attributed to differences in soil conditions and altitude. It was observed that linalool and geraniol are the main components in Ocimum basilicum L. from Bangladesh, and the authors concluded that the oil composition could be dependent on climatic conditions [31]. In the present study, our results showed that geraniol and citral and the main constituents of O. basilicum L. in respect of West Bengal are condition. The observed variations may be due to different environmental and genetic factors and the nutritional status of the plants as well as other factors that can influence the oil composition.

Compound aRetention indices (RI) in min. bEssential oil (%)


aIdentification of oil components was based on their relative retention indices (retention times) with those of authentic standards.
bQuantitative estimation was done by analysis of FID area percent data.
3.2. Evaluation of Nontoxicity of Plant Extract

Physicochemical observations were recorded to determine potential toxic effects of infused plant material in the animals. No adverse effect such as behavioral changes, coat conditions alterations, discharge and movement abnormality was seen for both group II and group III animals. No mice were found to be died during the study and nonsignificant changes of body weight, serum biochemical parameters, and hematological parameters (Table 3) were due to normal growth of the animals. So, the selected dose of plant extract is nontoxic.

ParametersControlLower dose (50 mg/Kg body weight) Higher dose (1500 mg/Kg body weight)
(group I)(group II)(group III)

SGOT (IU/dL)40.75 ± 1.1241.08 ± 1.1940.96 ± 1.15
SGPT (IU/ dL)34.22 ± 1.1934.98 ± 1.1635.11 ± 1.13
ALP (IU/dL)81.12 ± 1.7880.56 ± 1.7680.01 ± 1.72
Bilirubin (mg/dL)0.86 ± 0.130.85 ± 0.110.86 ± 0.12
Cholesterol (mg/dL)149.25 ± 9.3150.33 ± 8.7150.69 ± 8.9
Total protein (mg/dL)6.90 ± 2.096.89 ± 2.016.98 ± 2.33
Urea (mg/dL)41.64 ± 1.3242.09 ± 1.2142.67 ± 1.31
Uric acid (mg/dL)5.48 ± 1.775.12 ± 1.565.19 ± 1.67
Creatinine (mg/mL)0.93 ± 0.120.91 ± 0.210.92 ± 0.18
RBC (× 1012/L)6.6 ± 0.126.6 ± 0.166.7 ± 0.13
Hb (g/dL)13.2 ± 0.2213.1 ± 0.2812.9 ± 0.31
WBC (× 109/L)31.3 ± 0.4231.2 ± 0.0.3832.1 ± 0.26
Platelet (× 109/L)756 ± 41.2736 ± 46.1750 ± 42.4
Body weight (g)23 ± 1.223 ± 1.523 ± 1.4

3.3. Plant Material Arrest Benzene-Induced Cell Cycle Deregulation

Reduced expression of cell cycle regulatory proteins such as p53 and p21 has been implicated in benzene-induced hematotoxicity in mice [26]. Based on our results, we hypothesized that the plant extract might have modulatory effects on cell cycle regulatory proteins. As shown in Figure 2, it is evident that the expression levels of cyclins (cyclins D1, E), CDK2, CDK4, and CDK6 were considerably higher in benzene-induced mice compared with control mice. However, treatment of mice with the material after benzene exposure resulted in inhibition of benzene-induced expression levels of cyclins (cyclins D1, E), CDK2, CDK4 and CDK6 compared with proteins obtained from nontreated mice. The level of Cip1/p21, which is a universal inhibitor of cell cycle progression, is transcriptionally activated by p53 after benzene exposure [26, 32]. Treatment of plant material resulted in the enhancement of the levels of p21 and p53 in benzene-exposed mice compared with nontreated benzene exposed mice.

Mice exposed to benzene affect cell cycle regulators in bone marrow and blood. Regulation of cyclin-CDK complexes plays a key role in cell cycle progression at different phases in which CDKs are negatively regulated by a group of functionally related proteins known as CDK inhibitors, such as Kip/Cip family members [3335]. p21 is a universal CDK inhibitor and p21 inhibits DNA replication process [36, 37], whereas p53 is upregulated in response to antiproliferative signals. Consistent with these reports, methanolic leaf extract treatment resulted in an upregulation of p53 and p21 and significantly reduced level of CDK4 and CDK6, cyclin D1, and moderately reduced level of CDK2 and cyclin E in benzene-induced animal with hematotoxicity, which may have caused cell cycle arrest mainly in G2 phase in hematopoietic cells. Thus, it can be suggested that modulation in cell cycle progression and inhibition of cell proliferation could be one of the possible mechanisms through which the leaf extract inhibits benzene-induced cell cycle deregulation.

3.4. Hematological Parameters

The results shown in Table 4 indicate that the number of RBC, WBC, and Hb (g%) has been decreased in benzene-exposed group compared to control group of animals. Hb (g%), RBC and WBC have been decreased to 9.96 ± 1.3, 2.11 ± 0.19, and 3.28 ± 0.45, respectively. After treatment of benzene-exposed mice with the plant leaf extract the above parameters increase significantly ( 𝑃 < 0 . 0 5 ) and the value reaches to 1 1 . 9 6 ± 1 . 2 2 , 3 . 2 6 ± 0 . 3 3 , and 4 . 6 7 ± 0 . 3 1 , respectively. This result is also in accordance with overexpression of p21 in plant extract-treated group of animals as shown in immunoblot analysis. Among total WBC count, lymphocyte count increases significantly ( 𝑃 < 0 . 0 5 ) after treatment with the plant extract. Hct as RBC differential also increased significantly ( 𝑃 < 0 . 0 5 ) after treatment (Table 5).

GroupHb (g%)RBC (× 1012/L)WBC (× 109/L)

Control13.29 ± 2.14.08 ± 0.388.21 ± 1.2
BE9.96 ± 1.32. 11 ± 0.193.28 ± 0.45
Treated with PE11.96 ± 1.22*3.26 ± 0.33*4.67 ± 0.31*

*Significant increase ( 𝑃 < 0 . 0 5 ) in parameters.

GroupDifferential leukocyte countDifferential of RBCPlatelet count
Neutrophil (%)Monocyte (%)Lymphocyte (%)Hct (%)MCV ( 𝜇 m3)MCH (pg)MCHC (g/dL)(× 109/L)

Control22.03 ± 1.981.92 ± 0.0668.34 ± 5.1238.09 ± 2.1152.78 ± 3.4616.22 ± 0.1226.44 ± 0.35750 ± 38.21
BE21.68 ± 1.321.88 ± 0.0548.49 ± 3.5110.23 ± 0.9647.55 ± 2.9814.11 ± 0.1424.33 ± 0.38798 ± 40.08
Treated with PE21.92 ± 1.411.90 ± 0.0662.12 ± 4.98*24.35 ± 1.67*48.34 ± 2.7614.56 ± 0.1324.49 ± 0.36776 ± 39.97

*Significant increase (P <0.05) in parameters.

Blood parameters analysis is relevant to risk evaluation as the hematological system has a higher predictive value for toxicity in humans (91%) when assay involve rodents and nonrodents [38]. Blood is an important index of physiological and pathological status in man and animals and the parameters usually measured are hemoglobin, total red blood cell (RBC), and leukocyte (WBC) counts [39]. The hematotoxicity of benzene is characterized by suppression of erythromyelopoiesis, resulting in the depression of leukocyte (lymphocyte count mainly) and erythrocyte levels in peripheral blood [32, 40]. This result is also in accordance with overexpression of p21 as shown in immunoblot analysis (Figure 2). But after treatment with the plant material, decrease in blood parameters was found to be less.

3.5. DNA Fragmentation Analysis

As shown in Figure 3, DNA fragmentation assay of bone marrow cells characteristic of apoptosis was clearly detected after benzene exposure to mice and it is being less fragmented in methanolic leaf extract treated group. The data were coincident with the results of the cell cycle regulating kinases.

4. Conclusion

In conclusion, protection by plant secondary metabolites is currently an important strategy for controlling the process of various diseases including hematotoxicity. Therefore, there is a need to explore medicinal plants or other natural agents that can work as protective agents against hematotoxicity. In the present work, our results show significant activity of methanolic leaf extract of Ocimum basilicum L. against benzene-induced hematotoxicity in mice. These extract may promote chemopreventive activity in human. On the basis of above evidence, it is possible that monoterpenes like geraniol, citral, and eugenol, present in the extract may be responsible for this activity. However, this claim demands extensive studies on synergistic pharmacodynamic interactions of the phytochemicals as well as the effects on signal modulation which are essential for the development of multiactive natural drugs from Ocimum basilicum L. for cancer chemoprevention in the near future.


The authors acknowledge financial support from University Grant Commission (UGC), New Delhi, Govt. of India & Council of Scientific Industrial Research, New Delhi, Govt. of India. They are also grateful to DST-FIST programme, Govt. of India, Department of Botany and Department of Zoology, University of Kalyani for Instrumental facilities. There is no conflict of interests regarding the primary interest as well as secondary interest of the authors on the study in the mentioned field of research and publication.


  1. J. D. McChesney, S. K. Venkataraman, and J. T. Henri, “Plant natural products: back to the future or into extinction?” Phytochemistry, vol. 68, no. 14, pp. 2015–2022, 2007. View at: Publisher Site | Google Scholar
  2. C. Bailly, “Ready for a comeback of natural products in oncology,” Biochemical Pharmacology, vol. 77, no. 9, pp. 1447–1457, 2009. View at: Publisher Site | Google Scholar
  3. D. S. Seigler, Plant Secondary Metabolism, Kluwer Academic, Boston, Mass, USA, 1998.
  4. J. B. Harborne, “Arsenal for survival: secondary plant products,” Taxon, vol. 49, no. 3, pp. 435–449, 2000. View at: Google Scholar
  5. D. J. McGarvey and R. Croteau, “Terpenoid metabolism,” Plant Cell, vol. 7, no. 7, pp. 1015–1026, 1995. View at: Publisher Site | Google Scholar
  6. S. Schulz, F. Uhling, and S. Ansorge, “Prenylated proteins and lymphocyte proliferation: inhibition by d-limonene and related monoterpenes,” European Journal of Immunology, vol. 24, no. 2, pp. 301–307, 1994. View at: Google Scholar
  7. P. L. Crowell, C. E. Elson, H. H. Bailey, A. Elegbede, J. D. Haag, and M. N. Gould, “Human metabolism of the experimental cancer therapeutic agent d-limonene,” Cancer Chemotherapy and Pharmacology, vol. 35, no. 1, pp. 31–37, 1994. View at: Publisher Site | Google Scholar
  8. S. G. Yu, L. A. Hildebrandt, and C. E. Elson, “Geraniol, an inhibitor of mevalonate biosynthesis, suppresses the growth of hepatomas and melanomas transplanted to rats and mice,” Journal of Nutrition, vol. 125, no. 11, pp. 2763–2767, 1995. View at: Google Scholar
  9. P. L. Crowell, “Prevention and therapy of cancer by dietary monoterpenes,” Journal of Nutrition, vol. 129, no. 3, pp. 775S–778S, 1999. View at: Google Scholar
  10. S. K. Jaganathan, A. Mazumdar, D. Mondhe, and M. Mandal, “Apoptotic effect of eugenol in human colon cancer cell lines,” Cell Biology International, vol. 35, no. 6, pp. 607–615, 2011. View at: Publisher Site | Google Scholar
  11. M. A. Morse and G. D. Stoner, “Cancer chemoprevention: principles and prospects,” Carcinogenesis, vol. 14, no. 9, pp. 1737–1746, 1993. View at: Google Scholar
  12. J. P. Brown, “A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds,” Mutation Research, vol. 75, no. 3, pp. 243–277, 1980. View at: Google Scholar
  13. S. J. Lee, K. Umano, T. Shibamoto, and K. G. Lee, “Identification of volatile components in basil (Ocimum basilicum L.) and thyme leaves (Thymus vulgaris L.) and their antioxidant properties,” Food Chemistry, vol. 91, no. 1, pp. 131–137, 2005. View at: Publisher Site | Google Scholar
  14. R. S. Deshpande and H. P. Tipnis, “Insecticidal activity of Ocimum basilicum L.,” Pesticides, vol. 11, pp. 11–12, 1977. View at: Google Scholar
  15. J. E. Simon, J. Quinn, and R. G. Murray, “Basil: a source of essential oils,” in Advances in New Crops, J. Janick and J. E. Simon, Eds., pp. 484–489, Timber, Portland, Ore, USA, 1999. View at: Google Scholar
  16. H. R. Juliani and J. E. Simon, “Antioxidant activity of basil,” in Trends in New Crops and New Uses, J. Janic and A. Whipkey, Eds., pp. 575–579, ASHS Press, Alexandria, Va, USA, 2002. View at: Google Scholar
  17. A. Caceres, O. Cano, B. Samayoa, and L. Aguilar, “Plants used in Guatemala for the treatment of gastrointestinal disorders. 1. Screening of 84 plants against enterobacteria,” Journal of Ethnopharmacology, vol. 30, no. 1, pp. 55–73, 1990. View at: Publisher Site | Google Scholar
  18. K. A. Qamar, A. Dar, B. S. Siddiqui et al., “Anticancer activity of Ocimum basilicum and the effect of ursolic acid on the cytoskeleton of MCF-7 human breast cancer cells,” Letters in Drug Design and Discovery, vol. 7, no. 10, pp. 726–736, 2010. View at: Google Scholar
  19. M. Carballo, M. L. Nigro, I. Fraga, and A. Gadano, “Ethylene oxide: cytogenetic and biochemical studies in persons occupationally exposed,” Environmental and Molecular Mutagenesis, vol. 23, pp. 7–12, 1994. View at: Google Scholar
  20. G. K. Raabe and O. Wong, “Leukemia mortality by cell type in petroleum workers with potential exposure to benzene,” Environmental Health Perspectives, vol. 104, no. 6, pp. 1381–1392, 1996. View at: Google Scholar
  21. M. Aksoy, S. Erdem, and G. DinCol, “Leukemia in shoe workers exposed chronically to benzene,” Blood, vol. 44, no. 6, pp. 837–841, 1974. View at: Google Scholar
  22. C. A. Snyder, B. D. Goldstein, and A. R. Sellakumar, “The inhalation toxicology of benzene: incidence of hematopoietic neoplasms and hematotoxicity in AKR/J and C57BL/6J mice,” Toxicology and Applied Pharmacology, vol. 54, no. 2, pp. 323–331, 1980. View at: Google Scholar
  23. A. I. Vogel, Textbook of Practical Organic Chemistry, The English Language Book Society and Longman, London, UK, 1978.
  24. J. N. Kasolo, G. S. Bimenya, L. Ojok, and J. W. Ogwal-okeng, “Phytochemicals and acute toxicity of Moringa oleifera roots in mice,” Journal of Pharmacognosy and Phytotherapy, vol. 3, pp. 38–42, 2011. View at: Google Scholar
  25. V. Sharma and D. Pandey, “Beneficial effects of Tinospora cordifolia on blood profiles in male mice exposed to lead,” Toxicology International, vol. 17, no. 1, pp. 8–11, 2010. View at: Publisher Site | Google Scholar
  26. B. I. Yoon, Y. Hirabayashi, Y. Kawasaki et al., “Mechanism of action of benzene toxicity: cell cycle suppression in hemopoietic progenitor cells (CFU-GM),” Experimental Hematology, vol. 29, no. 3, pp. 278–285, 2001. View at: Publisher Site | Google Scholar
  27. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at: Google Scholar
  28. R. J. Grayer, G. C. Kite, F. J. Goldstone, S. E. Bryan, A. Paton, and E. Putievsky, “Infraspecific taxonomy and essential oil chemotypes in sweet basil, Ocimum basilicum,” Phytochemistry, vol. 43, no. 5, pp. 1033–1039, 1996. View at: Publisher Site | Google Scholar
  29. M. Marotti, R. Piccaglia, and E. Giovanelli, “Differences in essential oil composition of basil (Ocimum basilicum L.) Italian cultivars related to morphological characteristics,” Journal of Agricultural and Food Chemistry, vol. 44, no. 12, pp. 3926–3929, 1996. View at: Google Scholar
  30. J. C. Chalchat, R. P. Garry, L. Sidibé, and M. Harama, “Aromatic plants of Mali (I): chemical composition of essential oils of Ocimum basilicum L.,” Journal of Essential Oil Research, vol. 11, no. 3, pp. 375–380, 1999. View at: Google Scholar
  31. L. Mondello, G. Zappia, A. Cotroneo et al., “Studies on the chemical oil-bearing plants of Bangladesh. Part VIII. Composition of some Ocimum oils, O. basilicum L. var. purpurascens; O. sanctum L. green; O. sanctum L. purple; O. americanum L., citral type; O. americanum L., camphor type,” Flavour and Fragrance Journal, vol. 17, no. 5, pp. 335–340, 2002. View at: Publisher Site | Google Scholar
  32. G. M. Farris, S. N. Robinson, K. W. Gaido et al., “Benzene-induced hematotoxicity and bone marrow compensation in B6C3F1 mice,” Toxicological Sciences, vol. 36, no. 2, pp. 119–129, 1997. View at: Google Scholar
  33. M. B. Kastan and J. Bartek, “Cell-cycle checkpoints and cancer,” Nature, vol. 432, no. 7015, pp. 316–323, 2004. View at: Publisher Site | Google Scholar
  34. K. Vermeulen, D. R. Van Bockstaele, and Z. N. Berneman, “The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer,” Cell Proliferation, vol. 36, no. 3, pp. 131–149, 2003. View at: Publisher Site | Google Scholar
  35. A. Satyanarayana and P. Kaldis, “Mammalian cell-cycle regulation: several cdks, numerous cyclins and diverse compensatory mechanisms,” Oncogene, vol. 28, no. 33, pp. 2925–2939, 2009. View at: Publisher Site | Google Scholar
  36. K. D. Park, S. G. Lee, S. U. Kim et al., “Anticancer activity of 3-O-acyl and alkyl-(-)-epicatechin derivatives,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 20, pp. 5189–5192, 2004. View at: Publisher Site | Google Scholar
  37. A. M. Abukhdeir and B. H. Park, “p21 and p27: roles in carcinogenesis and drug resistance,” Expert Reviews in Molecular Medicine, vol. 10, article e19, 2008. View at: Publisher Site | Google Scholar
  38. H. Olson, G. Betton, D. Robinson et al., “Concordance of the toxicity of pharmaceuticals in humans and in animals,” Regulatory Toxicology and Pharmacology, vol. 32, no. 1, pp. 56–67, 2000. View at: Publisher Site | Google Scholar
  39. O. W. Schalm, N. C. Jain, and E. C. J. Carroll, Veterinary Hematology, Lea and Febiger, Philadelphia, Pa, USA, 3rd edition, 1975.
  40. E. P. Cronkite, R. T. Drew, T. Inoue, Y. Hirabayashi, and J. E. Bullis, “Hematotoxicity and carcinogenicity of inhaled benzene,” Environmental Health Perspectives, vol. 82, pp. 97–108, 1989. View at: Google Scholar

Copyright © 2012 S. Saha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

5520 Views | 1766 Downloads | 6 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.